-
Novocure's Stock Gains 3% As Anthem Now Covers Optune For Its Members
Friday, February 12, 2016 - 9:01am | 240Shares of Novocure Ltd (NASDAQ: NVCR) were trading higher by more than 3 percent early Friday morning after the company announced that Anthem Inc (NYSE: ANTM) will begin covering its Optune therapy for members. Novocure's Optune is a portable, noninvasive device that delivers Tumor Treating...